Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Optimization of eIF4E-Binding Peptide Pep8 to Disrupt the RBM38-eIF4E Complex for Induction of p53 and Tumor Suppression

Frontiers in Oncology(2022)10.3389/fonc.2022.893062Source: DataRank Database

Optimization of eIF4E-Binding Peptide Pep8 to Disrupt the RBM38-eIF4E Complex for Induction of p53 and Tumor Suppression is a research paper published in Frontiers in Oncology (2022). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)OA: goldTopics (27)IDs (PubMed)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Jin Zhang ORCID,Demitria M. Vasilatis ORCID,Elizabeth Yip,Xinbin Chen ORCID,Christopher A. Lucchesi ORCID

Live enrichment

PubMed:35574389

National Institutes of Health

Grant: RO1 CA250338, RO1 CA081237, T32 CA108459, T32 OD01147

National Institutes of Health

Grant: 5T32CA108459-14

Training Program in Oncogenic Signals and Chromosome Biology

National Institutes of Health

Grant: 1R01CA250338-01

Mechanism of p53-dependent Tumor Suppression

National Institutes of Health

Grant: 5R01CA081237-18

Mechanism of P73-Dependent Tumor Suppression

goldLicense: cc-by

publisherhttps://doi.org/10.3389/fonc.2022.893062

publisherhttps://www.frontiersin.org/articles/10.3389/fonc.2022.893062/full

repositoryhttps://doaj.org/article/474d26c584464e12832d09e5fcb5c78a

repositoryhttps://escholarship.org/uc/item/68m546nx

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9095979

Fields of Study

0301 basic medicine03 medical and health sciences

Keywords

p53Oncology and Carcinogenesis610Clinical sciencesRBM385.1 Pharmaceuticals (hrcs-rac)Genetics3211 Oncology and carcinogenesis (for-2020)32 Biomedical and Clinical Sciences (for-2020)radiotherapyRC254-282CancerCancer (rcdc)Biomedical and Clinical ScienceseIF4E-binding peptideGenetics (rcdc)Neoplasms. Tumors. Oncology. Including cancer and carcinogensCancer (hrcs-hc)3202 Clinical sciences (for-2020)1112 Oncology and Carcinogenesis (for)540peptideOncology5.1 PharmaceuticalseIF4E

Sustainable Development Goals

SDG 3: 3. Good health